大规模质量改进协作减少产后出血导致的严重孕产妇发病率种族差异
本研究评估了加利福尼亚州99家医院参与的产品出血质量改进协作对严重孕产妇发病率种族差异的影响。研究纳入2011-2016年间54,311名基线期和19,165名干预后期因产科出血住院的产妇。结果显示,干预后黑人和白人产妇的严重发病率均下降,且黑人下降幅度更大(9.0% vs 2.1%),黑人-白人相对风险从1.34降至1.22,调整混杂因素后从1.22降至1.07。
要点
- 质量改进协作实施产后出血安全套餐可降低所有种族严重孕产妇发病率。
- 黑人产妇严重发病率下降幅度(9.0%)大于白人(2.1%),差异缩小。
- 剖宫产是导致黑人严重发病率差异的最重要临床风险因素。
核心结论
- 大规模质量改进协作降低了所有种族的产品出血相关严重孕产妇发病率,并缩小了黑人与白人之间的差异。
研究设计与样本
- 横断面研究,纳入2011-2016年加州99家参与产后出血质量改进协作的医院。
主要发现
- 基线期严重孕产妇发病率总体为22.1%(12,002/54,311),黑人最高28.6%(973/3404),白人最低19.8%(3124/15,775)。
- 干预后期总体发病率降至18.5%(3553/19,165)。
- 黑人绝对发病率下降9.0%,白人下降2.1%。
- 基线黑人-白人相对风险为1.34(95%CI 1.27-1.42),干预后期降至1.22(95%CI 1.05-1.40)。
- 调整社会人口学和临床因素后,黑人-白人相对风险从基线1.22(95%CI 1.15-1.30)降至干预后期1.07(95%CI 1.92-1.24)。
关键数值与推荐
- 质量改进协作实施国家孕产妇出血安全套餐,包含17条基于证据的实践和护理流程推荐。
- 排除单纯输血病例后,调整风险因素的黑人-白人相对风险从基线1.33(95%CI 1.16-1.52)降至干预后期0.99(95%CI 0.76-1.29)。
临床怎么用
- 推广产后出血安全套餐可减少严重孕产妇发病率并缩小种族差异。
- 剖宫产是导致差异的重要临床风险因素,可作为质量改进的额外机会。
- 改善高效治疗的可及性可能减少护理敏感的急性医院相关疾病的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eliminating persistent racial/ethnic disparities in maternal mortality and morbidity is a public health priority. National strategies to improve maternal outcomes are increasingly focused on quality improvement collaboratives. However, the effectiveness of quality collaboratives for reducing racial disparities in maternity care is understudied. OBJECTIVE: To evaluate the impact of a hemorrhage quality-improvement collaborative on racial disparities in severe maternal morbidity from hemorrhage. STUDY DESIGN: We conducted a cross-sectional study from 2011 to 2016 among 99 hospitals that participated in a hemorrhage quality improvement collaborative in California. The focus of the quality collaborative was to implement the national maternal hemorrhage safety bundle consisting of 17 evidence-based recommendations for practice and care processes known to improve outcomes. This analysis included 54,311 women from the baseline period (January 2011 through December 2014) and 19,165 women from the postintervention period (October 2015 through December 2016) with a diagnosis of obstetric hemorrhage during delivery hospitalization. We examined whether racial/ethnic-specific severe maternal morbidity rates in these women with obstetric hemorrhage were reduced from the baseline to the postintervention period. In addition, we conducted Poisson Generalized Estimating Equation models to estimate relative risks and 95% confidence intervals for severe maternal morbidity comparing each racial/ethnic group with white. RESULTS: During the baseline period, the rate of severe maternal morbidity among women with hemorrhage was 22.1% (12,002/54,311) with the greatest rate observed among black women (28.6%, 973/3404), and the lowest among white women (19.8%, 3124/15,775). The overall rate fell to 18.5% (3553/19,165) in the postintervention period. Both black and white mothers benefited from the intervention, but the benefit among black women exceeded that of white women (9.0% vs 2.1% absolute rate reduction). The baseline risk of severe maternal morbidity was 1.34 times greater among black mothers compared with white mothers (relative risk, 1.34; 95% confidence interval, 1.27-1.42), and it was reduced to 1.22 (1.05-1.40) in the postintervention period. Sociodemographic and clinical factors explained a part of the black-white differences. After controlling for these factors, the black-white relative risk was 1.22 (95% confidence interval, 1.15-1.30) at baseline and narrowed to 1.07 (1.92-1.24) in the postintervention period. Results were similar when excluding severe maternal morbidity cases with transfusion alone. After accounting for maternal risk factors, the black-white relative risk for severe maternal morbidity excluding transfusion alone was reduced from a baseline of 1.33 (95% confidence interval, 1.16-1.52) to 0.99 (0.76-1.29) in the postintervention period. The most important clinical risk factor for disparate black rates for both severe maternal morbidity and severe maternal morbidity excluding transfusion alone was cesarean delivery, potentially providing another opportunity for quality improvement. CONCLUSION: A large-scale quality improvement collaborative reduced rates of severe maternal morbidity due to hemorrhage in all races and reduced the performance gap between black and white women. Improving access to highly effective treatments has the potential to decrease disparities for care-sensitive acute hospital-focused morbidities.
引用
- Main EK, Chang SC, Dhurjati R, et al. Reduction in racial disparities in severe maternal morbidity from hemorrhage in a large-scale quality improvement collaborative. Am J Obstet Gynecol. 2020. PMID: 31978432. doi:10.1016/j.ajog.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。